Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19?

In conclusion, we suggest that cystic fibrosis mutation carriers are potential members of a certain vulnerable group and the detection of such mutations in the population might be vital for the prevention of SARS-CoV-2 virus, and more specifically to limit its serious complications.
PMID: 33009727 [PubMed - as supplied by publisher]

Source: J Cell Mol Med - October 2, 2020 Category: Molecular Biology Authors: Sarantis P, Koustas E, Papavassiliou AG, Karamouzis MV Tags: J Cell Mol Med Source Type: research